Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

dc.contributor.authorElif Nurtop
dc.contributor.authorPaola Mariela Saba Villarroel
dc.contributor.authorBoris Pastorino
dc.contributor.authorLäétitia Ninove
dc.contributor.authorJan Felix Drexler
dc.contributor.authorYelin Roca
dc.contributor.authorBouba Gaké
dc.contributor.authorAudrey Dubot‐Pérès
dc.contributor.authorGilda Grard
dc.contributor.authorChristophe N. Peyrefitte
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:55:58Z
dc.date.available2026-03-22T13:55:58Z
dc.date.issued2018
dc.descriptionCitaciones: 66
dc.identifier.doi10.1186/s12985-018-1105-5
dc.identifier.urihttps://doi.org/10.1186/s12985-018-1105-5
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43564
dc.language.isoen
dc.publisherBioMed Central
dc.relation.ispartofVirology Journal
dc.sourceInstitut de Recherche pour le Développement
dc.subjectSeroprevalence
dc.subjectZika virus
dc.subjectVirology
dc.subjectDengue fever
dc.subjectBiology
dc.subjectPopulation
dc.subjectDengue virus
dc.subjectCytopathic effect
dc.subjectVirus
dc.subjectAntibody
dc.titleCombination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies
dc.typearticle

Files